DE69321914T2 - Antikörper gegen Plasmodium falciparum - Google Patents

Antikörper gegen Plasmodium falciparum

Info

Publication number
DE69321914T2
DE69321914T2 DE69321914T DE69321914T DE69321914T2 DE 69321914 T2 DE69321914 T2 DE 69321914T2 DE 69321914 T DE69321914 T DE 69321914T DE 69321914 T DE69321914 T DE 69321914T DE 69321914 T2 DE69321914 T2 DE 69321914T2
Authority
DE
Germany
Prior art keywords
hrp
antibody
peptide
monoclonal antibody
plasmodium falciparum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69321914T
Other languages
German (de)
English (en)
Other versions
DE69321914D1 (de
Inventor
Hans H. Parkton Maryland 21120 Feindt
Gerald D. Severn Maryland 21144 Hahn
Melissa S. Laytonsville Maryland 20760 Maret
Keith West Friendship Maryland 21794 Uithoven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Application granted granted Critical
Publication of DE69321914D1 publication Critical patent/DE69321914D1/de
Publication of DE69321914T2 publication Critical patent/DE69321914T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69321914T 1992-09-11 1993-08-27 Antikörper gegen Plasmodium falciparum Expired - Fee Related DE69321914T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94528792A 1992-09-11 1992-09-11

Publications (2)

Publication Number Publication Date
DE69321914D1 DE69321914D1 (de) 1998-12-10
DE69321914T2 true DE69321914T2 (de) 1999-03-25

Family

ID=25482919

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69321914T Expired - Fee Related DE69321914T2 (de) 1992-09-11 1993-08-27 Antikörper gegen Plasmodium falciparum

Country Status (10)

Country Link
US (3) US5478741A (OSRAM)
EP (1) EP0588122B1 (OSRAM)
JP (1) JP2537589B2 (OSRAM)
AU (2) AU670108B2 (OSRAM)
CA (1) CA2104899C (OSRAM)
DE (1) DE69321914T2 (OSRAM)
ES (1) ES2124276T3 (OSRAM)
MY (1) MY109957A (OSRAM)
SG (1) SG48314A1 (OSRAM)
TW (1) TW258738B (OSRAM)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
GB9505447D0 (en) * 1995-03-17 1995-05-03 Common Services Agency Competitive binding assay
US20030036106A1 (en) * 1996-10-28 2003-02-20 Burke Thomas J. Kinase and phosphatase activity measurement using fluorescence polarization
WO1998051794A1 (en) * 1997-05-14 1998-11-19 Human Genome Sciences, Inc. Antimicrobial peptide
US20020102620A1 (en) * 1999-05-07 2002-08-01 S. Melissa Maret Antibodies and peptides for detection of plasmodium vivax
WO2000079283A1 (en) 1999-06-23 2000-12-28 Cornell Research Foundation, Inc. Dehydration/rehydration of marked liposomes on a test device
US6576460B1 (en) 1999-10-28 2003-06-10 Cornell Research Foundation, Inc. Filtration-detection device and method of use
WO2003102541A2 (en) 2002-05-31 2003-12-11 Cornell Research Foundation, Inc. Universal biosensor and methods of use
AU2003270619A1 (en) 2002-09-12 2004-04-30 Molecular Probes, Inc. Site-specific labeling of affinity tags in fusion proteins
FR2865541B1 (fr) * 2003-05-20 2006-08-11 Commissariat Energie Atomique Procede de detection de fluorure ou de fluorure d'hydrogene et trousse de detection
EP1718967B1 (en) * 2004-02-03 2013-04-24 Diadexus, Inc. METHODS OF DETECTING Lp-PLA2 ACTIVITY
KR101035111B1 (ko) * 2004-06-30 2011-05-19 주식회사 엘지생명과학 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단
JP4508765B2 (ja) * 2004-08-02 2010-07-21 東洋紡績株式会社 ペプチドの固定化方法
JP4599928B2 (ja) * 2004-08-02 2010-12-15 東洋紡績株式会社 ペプチドの固定化方法
WO2006081308A2 (en) * 2005-01-25 2006-08-03 The Johns Hopkins University Plasmodium diagnostic assay device
ES2353212T3 (es) * 2005-03-30 2011-02-28 Saladax Biomedical Inc. Inmunoensayo de doxorrubicina.
US20070072242A1 (en) * 2005-09-22 2007-03-29 Randox Laboratories Limited Immunoassay method and kit to leucomalachite green and malachite green
EP1991273B2 (en) * 2006-02-10 2022-01-05 Life Technologies Corporation Labeling and detection of post translationally modified proteins
CA2653408C (en) * 2006-05-27 2017-08-01 Mitchell A. Winnik Polymer backbone element tags
WO2008008797A2 (en) 2006-07-10 2008-01-17 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
PT2047270E (pt) * 2006-07-28 2013-10-17 Beckman Coulter Inc Agentes de estabilização e ligandos de captura para utilização em ensaios de medição de concentrações de analito
WO2008100344A2 (en) 2006-10-06 2008-08-21 Sirigen Inc. Fluorescent methods and materials for directed biomarker signal amplification
TWI368905B (en) 2006-11-17 2012-07-21 Princeton Technology Corp Circuits for generating radio frequency zero cross signal of optical disc drive
US9239329B2 (en) * 2006-12-18 2016-01-19 Japan Science And Technology Agency Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods
FR2914066B1 (fr) * 2007-03-20 2009-05-22 Polyintell Sarl Kit d'analyse comprenant au moins deux polymeres a empreintes moleculaires et au moins un marqueur, ainsi que le procede d'analyse l'utilisant
US8320230B2 (en) 2007-05-17 2012-11-27 Mediatek Inc. Processing circuits and methods for optical data
US7943370B2 (en) * 2007-08-23 2011-05-17 Canon Kabushiki Kaisha Structure, target substance detection element and target substance detection kit
WO2009097159A1 (en) * 2008-02-02 2009-08-06 Tropical Health Systems Llc A blood purification method and appartus for the treatment of malaria
WO2010051544A2 (en) * 2008-10-31 2010-05-06 Lumiphore, Inc. Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
EP2816038B8 (en) 2009-08-24 2019-12-25 Lumiphore, Inc. Hopo chelators
EP3263562A1 (en) * 2009-12-24 2018-01-03 Lumiphore, Inc. Radiopharmaceutical complexes
WO2011119609A1 (en) * 2010-03-23 2011-09-29 Board Of Trustees Of Michigan State University Histidine rich protein-2 diagnostic test for cerebral malaria
EP2611827A4 (en) * 2010-09-03 2014-03-19 Univ Oregon Health & Science RECOMBINANT T-CELL RECEPTOR LIGANDS WITH Covalently Bonded PEPTIDES
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
EP3077815B1 (en) * 2013-12-03 2019-07-17 President and Fellows of Harvard College Methods and reagents for the assessment of gestational diabetes
GB201409516D0 (en) * 2014-05-29 2014-07-16 Randox Lab Ltd Immunoassay for compounds of the NBOMe family
EP3265074B1 (en) * 2015-03-03 2020-08-12 ARK Diagnostics, Inc. Pregabalin immunoassays
EP3288912A4 (en) * 2015-05-01 2018-11-07 Biolegend, Inc. Stable nanomagnetic particle dispersions
KR102705120B1 (ko) * 2016-02-26 2024-09-09 어질런트 테크놀러지스, 인코포레이티드 친핵체의 표지화를 개선시키기 위한 비스피리딘의 용도
EP3440463B1 (en) * 2016-04-05 2020-07-08 Université de Strasbourg Intra-droplet surface engineering to capture a molecular target
WO2017190117A1 (en) 2016-04-30 2017-11-02 BioLegend, Inc. Compositions and methods for performing magnetibuoyant separations
JP7303182B2 (ja) 2017-04-21 2023-07-04 メリタス エルエルシー 糖尿病関連用途のための方法及び抗体
CN120801474A (zh) * 2018-04-13 2025-10-17 富鲁达加拿大公司 用于元素分析的稳定细胞采集
CN111378034B (zh) * 2018-12-29 2021-10-12 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii抗体
CN111378035B (zh) * 2018-12-29 2021-10-08 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii重组抗体
CN114605533B (zh) * 2020-12-08 2023-02-28 东莞市朋志生物科技有限公司 抗恶性疟原虫hrp-ii的抗体、检测恶性疟原虫的试剂和试剂盒
US20220214350A1 (en) * 2021-01-05 2022-07-07 Encodia, Inc. Methods for stable complex formation and related kits

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE388694B (sv) 1975-01-27 1976-10-11 Kabi Ab Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4666866A (en) 1983-04-19 1987-05-19 Krauth Gary H Immunoassay for antigens employing supported binder
US4493795A (en) * 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US4695554A (en) 1984-02-14 1987-09-22 Becton Dickinson And Company Sac or liposome containing dye (sulforhodamine) for immunoassay
US4743560A (en) 1984-03-26 1988-05-10 Becton Dickinson And Company Solid phase assay
US4632901A (en) 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
GB2169901A (en) 1984-12-11 1986-07-23 Lkb Biochrom Ltd method for a solid phase synthesis of a linear combination of amino acid residues.
WO1986006075A1 (en) * 1985-04-11 1986-10-23 The Walter And Eliza Hall Institute Of Medical Res Highly repetitive antigens of plasmodium falciparum
AU5603786A (en) * 1985-04-11 1986-10-16 Walter And Eliza Hall Institute Of Medical Research, The Highly repetitive antigens - sharp-arp-mesa-plasmodium falciparum
US5130416A (en) * 1986-08-13 1992-07-14 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum
US5030558A (en) 1986-11-07 1991-07-09 Syntex (U.S.A.) Inc. Qualitative immunochromatographic method and device
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
US4920046A (en) 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
US4855240A (en) 1987-05-13 1989-08-08 Becton Dickinson And Company Solid phase assay employing capillary flow
AU2384688A (en) * 1987-09-04 1989-03-31 Georgetown University Monoclonal antibodies to a plasmodium falciparum protein
DE3737238A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
US4818677A (en) 1987-12-03 1989-04-04 Monoclonal Antibodies, Inc. Membrane assay using focused sample application
US5096837A (en) 1990-02-08 1992-03-17 Pacific Biotech, Inc. Immunochromatographic assay and method of using same
EP0474891A1 (en) * 1990-09-08 1992-03-18 BEHRINGWERKE Aktiengesellschaft Vectors for expression of malarial antigens on the surface of Salmonella vaccine strains
JP2002054521A (ja) 2000-08-11 2002-02-20 Honda Motor Co Ltd エンジンの燃料ポンプ取付構造

Also Published As

Publication number Publication date
EP0588122A1 (en) 1994-03-23
JPH06225789A (ja) 1994-08-16
AU6449996A (en) 1996-12-12
ES2124276T3 (es) 1999-02-01
US5478741A (en) 1995-12-26
AU683000B2 (en) 1997-10-23
MY109957A (en) 1997-10-31
JP2537589B2 (ja) 1996-09-25
CA2104899A1 (en) 1994-03-12
US5604117A (en) 1997-02-18
EP0588122B1 (en) 1998-11-04
AU670108B2 (en) 1996-07-04
DE69321914D1 (de) 1998-12-10
SG48314A1 (en) 1998-04-17
TW258738B (OSRAM) 1995-10-01
CA2104899C (en) 2000-10-17
US5665552A (en) 1997-09-09
AU4487293A (en) 1994-03-17

Similar Documents

Publication Publication Date Title
DE69321914T2 (de) Antikörper gegen Plasmodium falciparum
DE69622385T2 (de) Verbindungen und verfahren zum nachweis von t. cruzi-infektion
DE69432629T2 (de) Antikörper gegen beta-amyloid oder derivative davon und seine verwendung
DE69733560T2 (de) TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP
Kaushal et al. Monoclonal antibodies against surface determinants on gametes of Plasmodium gallinaceum block transmission of malaria parasites to mosquitoes.
DE69321955T2 (de) Bnp antikörper und immunologischer nachweis der ihn benutzt
DE69228436T2 (de) Monoklonaler Antikörper, der den C-Terminus von hBNP erkennt
Butterworth et al. Immunity in human schistosomiasis mansoni: cross-reactive IgM and IgG2 anti-carbohydrate antibodies block the expression of immunity
DE60224346T2 (de) Monoklonales Antikörper gegen das HCV Kernantigen
EP1110970B1 (de) Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung
DE3486159T2 (de) Schuetzendes peptid-antigen.
DE69132122T2 (de) Reinigung von cytokeratinfragmenten
DE69504620T2 (de) Monoklonaler Antikörper gegen menschliches Glicentin, Hybridoma zur Herstellung dieses Antikörpers und Testverfahren für menschliches Glicentin unter Verwendung dieses Antikörpers
DE60219645T2 (de) Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
DE69619405T2 (de) Verbindungen und verfahren zum nachweis und zur vorbeugung von t.cruzi infektionen
EP0142345A2 (en) Anti-idiotypic vaccine employing anti-idiotypic monoclonal antibodies
DE69733957T2 (de) Verfahren zur bestimmung der gegenwart des gehirnspezifischen proteins s-100 beta
EP0470565B1 (de) Peptide mit für alpha-1-Mikroglobulin charakteristischer antigener Determinante
DE69229230T2 (de) Antikörpertest zur erkennung von alkoholikern und zur überwachung der alkoholaufnahme
DE69230614T2 (de) Protein-s polypeptide und deren verwendungen
AU618024B2 (en) Antibodies to angiogenin: immunotherapeutic agents
US20020102620A1 (en) Antibodies and peptides for detection of plasmodium vivax
DE69229948T2 (de) hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN
DE68917797T2 (de) Gegen menschliches Fibrinopepid A spezifische monoklonale Antikörper.
EP0338436A2 (de) Monoklonale Antikörper gegen das Neuropeptid Y, Verfahren zu ihrer Herstellung sowie ihre Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee